دورية أكاديمية

Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.

التفاصيل البيبلوغرافية
العنوان: Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
المؤلفون: Maurya S; School of Health Sciences & Technology, UPES University, Dehradun, Uttarakhand, 248007, India., Srivastava R; Chemical & Biochemical Engineering, Indian Institute of Technology, Patna, 801106, India., Arfin S; School of Health Sciences & Technology, UPES University, Dehradun, Uttarakhand, 248007, India., Hawthorne S; SAAD Building, School of Pharmacy & Pharmaceutical Sciences, Ulster University, Coleraine, BT52 1SA, UK., Jha NK; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, Uttar Pradesh, 201310, India.; School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India., Agrawal K; School of Health Sciences & Technology, UPES University, Dehradun, Uttarakhand, 248007, India., Raj S; School of Health Sciences & Technology, UPES University, Dehradun, Uttarakhand, 248007, India., Rathi B; Department of Chemistry, Hansraj College, Delhi University, New Delhi, 110007, Delhi, India., Kumar A; Mahavir Cancer Institute & Research Centre Patna, Bihar, 800002, India., Raj R; Department of Biochemistry, Bangalore University, Bangalore, 560056, Karnataka, India., Agrawal S; Department of Life Sciences, School of Basic Science & Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India., Paiva-Santos AC; Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Azinhaga Sta. Comba, 3000-548 Coimbra, Portugal., Malik AA; Department of Life Sciences, School of Basic Science & Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India., Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia., Rana R; MSD, HILLEMAN LABS, Analytical Division, New Delhi, 110062, India., Ojha S; Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates., Jha SK; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, Uttar Pradesh, 201310, India.; Department of Biotechnology Engineering & Food Technology, Chandigarh University, Mohali, 140413, India.; Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun 248007, India., Sharma A; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Cathedral Street, Glasgow, G10RE, Scotland, UK., Kumar D; School of Health Sciences & Technology, UPES University, Dehradun, Uttarakhand, 248007, India., El-Zahaby SA; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt., Nagar A; Department of Life Sciences, School of Basic Science & Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India.
المصدر: Nanomedicine (London, England) [Nanomedicine (Lond)] 2022 Dec; Vol. 17 (30), pp. 2245-2264. Date of Electronic Publication: 2023 Mar 28.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101278111 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-6963 (Electronic) Linking ISSN: 17435889 NLM ISO Abbreviation: Nanomedicine (Lond) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London, UK : Future Medicine Ltd., c2006-
مواضيع طبية MeSH: Lung Diseases*/drug therapy , Nanoparticles*, Humans ; Nanomedicine/methods ; Drug Delivery Systems/methods ; Nanotechnology/methods ; Pharmaceutical Preparations ; Lung
مستخلص: Diagnosis and treatment of lung diseases pose serious challenges. Currently, diagnostic as well as therapeutic methods show poor efficacy toward drug-resistant bacterial infections, while chemotherapy causes toxicity and nonspecific delivery of drugs. Advanced treatment methods that cure lung-related diseases, by enabling drug bioavailability via nasal passages during mucosal formation, which interferes with drug penetration to targeted sites, are in demand. Nanotechnology confers several advantages. Currently, different nanoparticles, or their combinations, are being used to enhance targeted drug delivery. Nanomedicine, a combination of nanoparticles and therapeutic agents, that delivers drugs to targeted sites increases the bioavailability of drugs at these sites. Thus, nanotechnology is superior to conventional chemotherapeutic strategies. Here, the authors review the latest advancements in nanomedicine-based drug-delivery methods for managing acute and chronic inflammatory lung diseases.
فهرسة مساهمة: Keywords: biopharmacokinetic; cystic fibrosis; lung diseases; nanocarriers; nanomedicines; therapeutics
المشرفين على المادة: 0 (Pharmaceutical Preparations)
تواريخ الأحداث: Date Created: 20230328 Date Completed: 20230330 Latest Revision: 20230417
رمز التحديث: 20230418
DOI: 10.2217/nnm-2021-0437
PMID: 36975758
قاعدة البيانات: MEDLINE
الوصف
تدمد:1748-6963
DOI:10.2217/nnm-2021-0437